Tianjin Hongri Kangrentang Pharmaceutical

Tianjin Hongri Kangrentang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale production of Traditional Chinese Medicine (TCM) formula granules. As a core subsidiary of the Tianjin Hongri Pharmaceutical Group, the company has pioneered the modernization of herbal medicine by developing a portfolio of over 600 varieties of standardized formula granules. These products serve as high-tech, convenient alternatives to traditional herbal decoctions, maintaining the full spectrum of active components through advanced extraction and granulation processes. The company operates highly automated manufacturing facilities and utilizes a digitized quality control system to ensure consistency and safety across its product lines. Kangrentang holds a significant market share in China's TCM granule industry and is a key driver of the group's overall revenue and clinical impact.